sEphB4-HSA in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
Conditions
- Castration Levels of Testosterone
- Castration-Resistant Prostate Carcinoma
- Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents
- Metastatic Prostate Adenocarcinoma
- Progressive Disease
- Prostate Carcinoma Metastatic in the Bone
- Prostate Carcinoma Metastatic in the Soft Tissue
- PSA Progression
- Stage IVB Prostate Cancer AJCC v8
- Testosterone Less Than 50 ng/dL
Interventions
- BIOLOGICAL: Recombinant EphB4-HSA Fusion Protein
Sponsor
Northwestern University
Collaborators
- [object Object]
- [object Object]